1. Home
  2. ARVN vs LEGH Comparison

ARVN vs LEGH Comparison

Compare ARVN & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$7.26

Market Cap

600.2M

Sector

Health Care

ML Signal

HOLD

Logo Legacy Housing Corporation (TX)

LEGH

Legacy Housing Corporation (TX)

HOLD

Current Price

$27.92

Market Cap

691.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
LEGH
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
600.2M
691.6M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ARVN
LEGH
Price
$7.26
$27.92
Analyst Decision
Buy
Buy
Analyst Count
16
2
Target Price
$13.93
★ $28.00
AVG Volume (30 Days)
★ 646.8K
59.3K
Earning Date
11-04-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.84
N/A
EPS
★ 1.70
1.44
Revenue
★ $262,600,000.00
$164,567,000.00
Revenue This Year
$12.76
$23.39
Revenue Next Year
N/A
N/A
P/E Ratio
★ $4.54
$19.62
Revenue Growth
★ N/A
N/A
52 Week Low
$6.74
$18.29
52 Week High
$14.22
$31.34

Technical Indicators

Market Signals
Indicator
ARVN
LEGH
Relative Strength Index (RSI) 43.63 50.96
Support Level $6.74 $25.03
Resistance Level $7.74 $30.04
Average True Range (ATR) 0.36 0.82
MACD 0.08 -0.01
Stochastic Oscillator 51.43 55.34

Price Performance

Historical Comparison
ARVN
LEGH

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.

Share on Social Networks: